» Articles » PMID: 19293374

Evolution of Virulence in Epidemic Community-associated Methicillin-resistant Staphylococcus Aureus

Overview
Specialty Science
Date 2009 Mar 19
PMID 19293374
Citations 228
Authors
Affiliations
Soon will be listed here.
Abstract

Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) has recently emerged worldwide. The United States, in particular, is experiencing a serious epidemic of CA-MRSA that is almost entirely caused by an extraordinarily infectious strain named USA300. However, the molecular determinants underlying the pathogenic success of CA-MRSA are mostly unknown. To gain insight into the evolution of the exceptional potential of USA300 to cause disease, we compared the phylogeny and virulence of USA300 with that of closely related MRSA clones. We discovered that the sublineage from which USA300 evolved is characterized by a phenotype of high virulence that is clearly distinct from other MRSA strains. Namely, USA300 and its progenitor, USA500, had high virulence in animal infection models and the capacity to evade innate host defense mechanisms. Furthermore, our results indicate that increased virulence in the USA300/USA500 sublineage is attributable to differential expression of core genome-encoded virulence determinants, such as phenol-soluble modulins and alpha-toxin. Notably, the fact that the virulence phenotype of USA300 was already established in its progenitor indicates that acquisition of mobile genetic elements has played a limited role in the evolution of USA300 virulence and points to a possibly different role of those elements. Thus, our results highlight the importance of differential gene expression in the evolution of USA300 virulence. This finding calls for a profound revision of our notion about CA-MRSA pathogenesis at the molecular level and has important implications for design of therapeutics directed against CA-MRSA.

Citing Articles

in Inflammation and Pain: Update on Pathologic Mechanisms.

Rasquel-Oliveira F, Ribeiro J, Martelossi-Cebinelli G, Costa F, Nakazato G, Casagrande R Pathogens. 2025; 14(2).

PMID: 40005560 PMC: 11858194. DOI: 10.3390/pathogens14020185.


Novel anti-virulence compounds disrupt exotoxin expression in MRSA.

Balogh H, Anthony A, Stempel R, Vossen L, Federico V, Valenzano G Microbiol Spectr. 2024; :e0146424.

PMID: 39431895 PMC: 11619317. DOI: 10.1128/spectrum.01464-24.


Collaborative Cross mice have diverse phenotypic responses to infection with Methicillin-resistant Staphylococcus aureus USA300.

Nagarajan A, Scoggin K, Gupta J, Aminian M, Adams L, Kirby M PLoS Genet. 2024; 20(5):e1011229.

PMID: 38696518 PMC: 11108197. DOI: 10.1371/journal.pgen.1011229.


Prophage-encoded methyltransferase drives adaptation of community-acquired methicillin-resistant .

Ulrich R, Podkowik M, Tierce R, Irnov I, Putzel G, Samhadaneh N bioRxiv. 2024; .

PMID: 38659881 PMC: 11042277. DOI: 10.1101/2024.04.17.589803.


Targeting host-specific metabolic pathways-opportunities and challenges for anti-infective therapy.

Konaklieva M, Plotkin B Front Mol Biosci. 2024; 11:1338567.

PMID: 38455763 PMC: 10918472. DOI: 10.3389/fmolb.2024.1338567.


References
1.
Miller L, Quan C, Shay A, Mostafaie K, Bharadwa K, Tan N . A prospective investigation of outcomes after hospital discharge for endemic, community-acquired methicillin-resistant and -susceptible Staphylococcus aureus skin infection. Clin Infect Dis. 2007; 44(4):483-92. DOI: 10.1086/511041. View

2.
Beres S, Richter E, Nagiec M, Sumby P, Porcella S, DeLeo F . Molecular genetic anatomy of inter- and intraserotype variation in the human bacterial pathogen group A Streptococcus. Proc Natl Acad Sci U S A. 2006; 103(18):7059-64. PMC: 1459018. DOI: 10.1073/pnas.0510279103. View

3.
Enright M, Robinson D, Randle G, Feil E, Grundmann H, Spratt B . The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA). Proc Natl Acad Sci U S A. 2002; 99(11):7687-92. PMC: 124322. DOI: 10.1073/pnas.122108599. View

4.
Loughman J, Fritz S, Storch G, Hunstad D . Virulence gene expression in human community-acquired Staphylococcus aureus infection. J Infect Dis. 2009; 199(3):294-301. PMC: 2843142. DOI: 10.1086/595982. View

5.
Diep B, Gill S, Chang R, Phan T, Chen J, Davidson M . Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus. Lancet. 2006; 367(9512):731-9. DOI: 10.1016/S0140-6736(06)68231-7. View